Correspondence

You have full text access to this OnlineOpen article

Reply:†‡§

  1. M. Isabel Lucena1,
  2. Carmen Martínez2,
  3. Raúl J. Andrade3,
  4. Elena García-Martín4,
  5. Eugenia Ulzurrun1,
  6. José A. G. Agúndez2

Article first published online: 7 APR 2009

DOI: 10.1002/hep.22922

Issue

Hepatology

Hepatology

Volume 49, Issue 5, pages 1777–1779, May 2009

Additional Information

How to Cite

Lucena, M. I., Martínez, C., Andrade, R. J., García-Martín, E., Ulzurrun, E. and Agúndez, J. A. G. (2009), Reply:. Hepatology, 49: 1777–1779. doi: 10.1002/hep.22922

Author Information

  1. 1

    Facultad de Medicina, Hospital Universitario Virgen de la Victoria, Málaga, Spain

  2. 2

    Departamento de Farmacología, Facultad de Medicina, Universidad de Extremadura, Badajoz, Spain

  3. 3

    Unidad de Hepatología, Facultad de Medicina, Hospital Universitario Virgen de la Victoria, Málaga, Spain

  4. 4

    Departamento de Bioquímica y Biología Molecular y Genética, Facultad de Ciencias, Universidad de Extremadura, Badajoz, Spain

  1. †

    Potential conflict of interest: Nothing to report.

  2. ‡

    This letter was written on behalf of the Spanish Group for the Study of Drug-Induced Liver Disease (Grupo de Estudio para las Hepatopatias Asociadas a Medicamentos).

  3. §

    M. Isabel Lucena, Raúl J. Andrade, and Eugenia Ulzurrun are associated with the Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas. Carmen Martínez, Elena García-Martín, and José A. G. Agúndez are associated with the Red de Investigación de Reacciones Adversas a Alergenos y Fármacos.

Publication History

  1. Issue published online: 27 APR 2009
  2. Article first published online: 7 APR 2009
  3. Accepted manuscript online: 7 APR 2009 12:00AM EST

Funded by

  • EC. Grant Number: 07/90910

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS